Atypical Alzheimer's disease in an elderly United States resident with amyotrophic lateral sclerosis and pathological tau in spinal motor neurons

References

• Mackenzie IRA, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1–4.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–3.
   PubMed Web of Science ®Google Scholar
• Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, Brandmeir NJ, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180–9.
   PubMedGoogle Scholar
• Geser F, Prvulovic D, O’Dwyer L, Hardiman O, Bede P, Bokde ALW, et al. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog Neurobiol. 2011;95: 649–62.
   PubMed Web of Science ®Google Scholar
• Bäumer D, Hilton D, Paine SML, Turner MR, Lowe J, Talbot K, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010; 75:611–8.
   PubMed Web of Science ®Google Scholar
• Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, et al. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions. Brain Pathol. 2010;20:1069–76.
   PubMed Web of Science ®Google Scholar
• Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IRA. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132:2922–31.
   PubMed Web of Science ®Google Scholar
• Martinaud O, Laquerrière A, Guyant-Maréchal L, Ahtoy P, Vera P, Sergeant N, et al. Frontotemporal dementia, motor neuron disease and tauopathy: clinical and neuropathological study in a family. Acta Neuropathol. 2005;110:84–92.
   PubMed Web of Science ®Google Scholar
• Hilton DA, Love S, Ferguson I, Newman P. Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathol. 1995;90:101–6.
   PubMedGoogle Scholar
• Kuroda S, Otsuki S, Tateishi J, Hirano A. Neurofibrillary degeneration in a case of quadriplegia and myoclonic movement. Acta Neuropathol. 1979;45:105–9.
   PubMedGoogle Scholar
• Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJ, de Belleroche JS. Familial amyotrophic lateral sclerosis with a point mutation of SOD1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatr. 1995;59:266–70.
   PubMed Web of Science ®Google Scholar
• Piao Y-S, Tan C-F, Iwanaga K, Kakita A, Takano H, Nishizawa M, et al. Sporadic four-repeat tauopathy with frontotemporal degeneration, Parkinsonism and motor neuron disease. Acta Neuropathol. 2005;110:600–9.
   PubMed Web of Science ®Google Scholar
• Yokota O, Tsuchiya K, Oda T, Ishihara T, de Silva R, Lees AJ, et al. Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration. Acta Neuropathol. 2006;112: 633–45.
   PubMedGoogle Scholar
• Fu Y-J, Nishihira Y, Kuroda S, Toyoshima Y, Ishihara T, Shinozaki M, et al. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity. Acta Neuropathol. 2010;120: 21–32.
   PubMedGoogle Scholar
• Mimuro M, Kokubo Y, Kuzuhara S. Similar topographical distribution of neurofibrillary tangles in amyotrophic lateral sclerosis and Parkinsonism-dementia complex in people living in the Kii peninsula of Japan suggests a single tauopathy. Acta Neuropathol. 2007;113:653–8.
   PubMedGoogle Scholar
• Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain. 1961;84:662–79.
   PubMed Web of Science ®Google Scholar
• Hirano A, Zimmerman HM. Alzheimer's neurofibrillary changes: a topographic study. Arch Neurol. 1962;7:227–42.
   PubMedGoogle Scholar
• Trojanowski JQ, Ishihara T, Higuchi M, Yoshiyama Y, Hong M, Zhang B, et al. Amyotrophic lateral sclerosis/Parkinsonism dementia complex: transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam. Exp Neurol. 2002;176: 1–11.
   PubMed Web of Science ®Google Scholar
• Gentleman SM, Perl D, Allsop D, Clinton J, Royston MC, Roberts GW. β(A4)-amyloid protein and Parkinsonian dementia complex of Guam. Lancet. 1991;337:55–6.
   PubMedGoogle Scholar
• van Deerlin VM, Gill LH, Farmer JM, Trojanowski JQ, Lee VM-Y. Familial frontotemporal dementia: from gene discovery to clinical molecular diagnostics. Clin Chem. 2003;49:1717–25.
   PubMedGoogle Scholar
• van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409–16.
   PubMed Web of Science ®Google Scholar
• Luquin N, Yu B, Trent RJ, Morahan JM, Pamphlett R. An analysis of the entire SOD1 gene in sporadic ALS. Neuromuscul Disord. 2008;18:545–52.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, et al. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9orf72 hexanucleotide expansion. Acta Neuropathol. 2012;123:825–39.
   PubMed Web of Science ®Google Scholar
• Thal DR, Rüb U, Orantes M, Braak H. Phases of A β-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791–800.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Strong M, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathol. 2013; 126:537–44.
   PubMed Web of Science ®Google Scholar
• Yang W, Sopper MM, Leystra-Lantz C, Strong MJ. Microtubule associated tau protein-positive neuronal and glial inclusions in ALS. Neurology. 2003;61:1766–73.
   PubMed Web of Science ®Google Scholar
• Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, et al. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 2012;123: 395–407.
   PubMed Web of Science ®Google Scholar
• Hirano A, Kurland LT, Krooth RS, Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain. 1961;84:642–61.
   PubMed Web of Science ®Google Scholar
• Zarranz JJ, Ferrer I, Lezcano E, Forcadas MI, Eizaguirre B, Atarés B, et al. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology. 2005;64:1578–85.
   PubMed Web of Science ®Google Scholar
• Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron. 1999;24: 751–62.
   PubMedGoogle Scholar
• Probst A, Götz J, Wiederhold KH, Tolnay M, Mistl C, Jaton AL, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol. 2000;99:469–81.
   PubMed Web of Science ®Google Scholar
• Dugger BN, Hidalgo JA, Chiarolanza G, Mariner M, Henry-Watson J, Sue LI, et al. The distribution of phosphorylated tau in spinal cords of Alzheimer's disease and non-demented individuals. J Alzheimers Dis. 2013; 34:529–36.
   PubMedGoogle Scholar
• Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, et al. Pathological TDP-43 in Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 2008;115:133–45.
   PubMed Web of Science ®Google Scholar
• Saito Y, Murayama S. Expression of tau immunoreactivity in the spinal motor neurons of Alzheimer's disease. Neurology. 2000;55:1727–9.
   PubMedGoogle Scholar
• Schmidt ML, Zhukareva V, Perl DP, Sheridan SK, Schuck T, Lee VM, et al. Spinal cord neurofibrillary pathology in Alzheimer's disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol. 2001;60: 1075–86.
   PubMed Web of Science ®Google Scholar
• Malamud N, Hirano A, Kurland LT. Pathoanatomic changes in amyotrophic lateral sclerosis on Guam. Special reference to the occurrence of neurofibrillary changes. Arch Neurol. 1961;5:401–15.
   Google Scholar
• Thal DR, del Tredici K, Ludolph AC, Hoozemans JJM, Rozemuller AJ, Braak H, et al. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response. Acta Neuropathol. 2011;122: 577–89.
   PubMedGoogle Scholar
• Schmidt ML, Lee VM, Saido T, Perl D, Schuck T, Iwatsubo T, et al. Amyloid plaques in Guam amyotrophic lateral sclerosis/Parkinsonism-dementia complex contain species of Aβ similar to those found in the amyloid plaques of Alzheimer's disease and pathological aging. Acta Neuropathol. 1998;95:117–22.
   PubMedGoogle Scholar
• Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM-Y, Trojanowski JQ. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol. 2002;160:1725–31.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Arai T, Akiyama H, Nonaka T, Mori H, Hashimoto T, et al. TDP-43 is deposited in the Guam Parkinsonism-dementia complex brains. Brain. 2007; 130:1386–94.
   PubMed Web of Science ®Google Scholar